(+)-1R,3R(3S),5S-2,4,3-二氮磷杂二环[3.2.1]辛烷衍生物的不对称合成

用(+)-顺式-1R,3S-1,2,2-三甲基-1,3-环戊二胺1为手性诱导试剂分别和几类硫代磷酰二氯2a—k反应,合成了11个新型的含手性磷原子的(+)-1R,3RS,5S-2,4,3-二氮磷杂二环[3.2.1]辛烷的衍生物3a-k.3(1R,3Rs,5S)由两个不等量的非对映异构体3’(1R,3R,5S)和 3"(1R,3S,5S)组成,d.e.值对 3’为 6.2—83.6％,对3"为50.4—100％,表明3的合成是经过不对称反应实现的.苯氧基硫代磷酰二氯2e和1的反应具较高的光学选择性,产物中R磷原子异构体3’e的含量占90％;N,N-二烷基胺基硫代磷酰二氯2h,2i和1反应时,只得到含S磷原子的异构体3"h和3"i,为立体专一性反应.     

RuCl2[P(C6H5)3]2-(R,R)-DPEN催化萘乙酮不对称加氢反应

 合成了(R,R)-1,2-二苯基乙二胺((R,R)-DPEN)、 钌和三苯基膦的三元配合物RuCl2[P(C6H5)3]2-(R,R)-DPEN, 并将其用于萘乙酮的不对称加氢反应. 考察了碱/催化剂的摩尔比、反应温度和氢气压力等对催化活性和对映选择性的影响. 结果表明,多种因素对反应的转化率和对映选择性均有影响. 在萘乙酮:(CH3)3COK:催化剂摩尔比为 50000:450:1, 氢气压力为4 MPa, 反应温度为25 ℃的条件下,反应16 h时,萘乙酮生成α-萘乙醇的产率和对映选择性分别达到了100%和83%.     

氨基糖的研究Ⅲ——6-O-(N′-乙酰-2′-胺基-2′-脱羟-β-D-葡萄糖甙基)-N-乙酰-2-胺基-2-脱羟-D-葡萄糖的合成

作者用 Knigs-Knorr 的方法,从1,2,3,4-四乙酰-2-胺基-2-脱羟-β-D-葡萄糖和1-溴-2,3,4,6-四乙酰-2-胺基-2-脱羟-α-D-葡萄糖合成八乙酰异壳二糖,经氨解得二乙酰异壳二糖([6-O-N′-乙酰-2′-胺基-2′-脱羟-β-D-葡萄糖甙基]-N-乙酰-2-胺基-2-脱羟-D-葡萄糖)。     

从(-)-莽草酸出发合成(3R,5R)-3,4,5-三苯甲酰氧基环己酮

报道了一种合成手性中间体(3R,5R)-3,4,5-三羟基环己酮的新方法。首次以(-)-莽草酸为起始原料,经苯甲酰化、双键氢化、选择性还原甲酯、羟基碘代、碘代烃消除、双键双羟化、片哪醇断裂等步骤,以44.9%的总收率合成了(3R,5R)-3,4,5-三苯甲酰氧基环己酮,所有化合物的结构经¹H NMR、 ¹³C NMR、 IR及MS等确证。      

(2S,3R,7R/S)-3,7-二甲基-2-十三碳醇丙酸酯的全合成研究进展

靖远松叶蜂(Diprion jingyuanensis)是危害油松的一种叶蜂,其性信息素的活性成分为(2S,3R,7R/S)-3,7-二甲基-2-十三碳醇丙酸酯。本文根据C9+C6路径、C10+C5途径和其他路径对(2S,3R,7R/S)-3,7-二甲基-2-十三碳醇丙酸酯及其关键中间体的合成研究进行了综述。参考文献60篇。     

糖类研究(ⅩⅩⅩⅠ)--带连接臂的乳糖衍生物及二聚体的合成

八乙酰乳糖与一缩二乙二醇或二缩三乙二醇在BF3.Et2O催化下反应生成相应的β-糖苷,后者在同样的催化剂存在下再与八乙酰乳糖反应生成对称的β-构型二聚体.糖苷与二聚体在甲醇钠/甲醇溶液中脱去乙酰基生成目标化合物用于抗癌转移活性研究.     

糖类研究(ⅩⅩⅪ)带连接臂的乳糖衍生物及二聚体的合成

八乙酰乳糖与一缩二乙二醇或二缩三乙二醇在 BF3.Et2 O催化下反应生成相应的 β-糖苷 ,后者在同样的催化剂存在下再与八乙酰乳糖反应生成对称的 β-构型二聚体 .糖苷与二聚体在甲醇钠 /甲醇溶液中脱去乙酰基生成目标化合物用于抗癌转移活性研究 .     

神经节系列鞘糖脂氨基半乳糖模块的快速合成

以D-氨基半乳糖盐酸盐为原料,经四步反应合成了2-N-三氯乙氧羰酰氨基-半乳糖对甲苯硫苷(3);3经两步区域选择性乙酰化反应合成了4,6-O-二-乙酰基-2-N三氯乙氧羰酰氨基-2-脱氧-β-D-吡喃半乳糖对甲苯硫苷(总收率70%),其结构经1H NMR和ESI-MS确证。     

4-(二乙氨基)水杨醛席夫碱的合成、光谱性质和热稳定性及量化计算

合成了两种酰腙类席夫碱4-(二乙氨基)水杨醛噻吩-2-甲酰腙(H_2L~1)和4-(二乙氨基)水杨醛异烟酰腙一水合物(H_2L~2·H_2O),利用元素分析、IR光谱、UV光谱和FL光谱及热重分析对其进行了表征.实验结果表明,两种化合物在可见光区均可产生荧光,最大发射峰波长分别为504和525nm.热分解温度分别为254和278℃.用Gaussian 09程序包对H_2L~1进行了量化计算,结果表明,该化合物的水杨基和酰腙基是金属离子很好的配位点.     

β-(3,4-二羟基苯基)-α-羟基一N-[(R)-3-苯基-1-乙氧酰基丙基]丙酰胺的合成

以3,4-二羟基苯甲醛为原料,经开环、Knoevenagel缩合、水解和Clemmemen还原反应合成了丹参素(5);5与(R)-2-胺基-4-苯基丁酸乙酯在DCC/DMAP作用下,脱去一分子水合成了β-(3,4-二羟基苯基)-α-羟基-N-[(R)-3-苯基-1-乙氧酰基丙基]丙酰胺(8).8的结构经1H NMR,IR和MS表征.     

A Validated Chiral LC Method for the Separation and Quantification of (S,R,S)-Enantiomer and (R,R,R)-Isomer of Aprepitant

A new and accurate chiral liquid chromatographic method has been developed for the separation and quantification of (S,R,S)-enantiomer (unwanted enantiomer) and (R,R,R)-isomer (key intermediate) of aprepitant in bulk drug and formulation samples of apprepitant. The elution time was approximately 20 min using an immobilized amylose-based chiral stationary phase (Chiralpak-IA). The mobile phase was n-hexane and ethanol (90:10, v/v) and was delivered at a flow rate of 1.0 mL min^?1. Detection was carried out with a wavelength set to 220 nm. The resolution factor between enantiomers was found to be greater than five. Limit of detection for both (S,R,S) enantiomer and (R,R,R) isomer of aprepitant was 0.035 µg, and limit of quantification for both (S,R,S) enantiomer and (R,R,R) isomers of aprepitant was 0.1 µg, for a 10 µL injection. The developed method showed excellent linearity (r > 0.999) for both isomers. When the method was applied to bulk drug samples and in pharmaceutical formulations recoveries were obtained ranging from 97.2 to 103.1%. Aprepitant sample solutions were found to be stable when characterized over a period of 48 h.     

Convergent synthesis of (2R,3R,8R,9R)-N-Boc-ADDA

The convergent synthesis of N-Boc-(2R,3R,8R,9R,4E,6E)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecadenoic acid (enantio-N-Boc-ADDA) is reported. Our flexible approach takes advantage of highly efficient non-aldol aldol and cross-metathesis methodologies.     

Enantio- and diastereoselective synthesis of (R,R)-beta-methoxytyrosine

The nonproteinogenic amino acid (2R,3R)-beta-methoxytyrosine, a constituent of several cyclic depsipeptide natural products, was synthesized in protected form (8) from a readily available cinnamate ester in four steps and 62% overall yield with a greater than 28:1 er and 19:1 dr. This method provides a highly efficient, enantio- and diastereoselective synthesis of an important amino acid.     

Clathrate hydrate dissociation conditions of refrigerants R404A,R406A,R408A and R427A: Experimental measurements and thermodynamic modeling

Clathrate hydrate dissociation conditions were measured for four “alternative” refrigerants, viz. R404A, R406A, R408A and R427A. The experimental measurements were performed within the pressure range of (0.079 to 9.995) MPa and temperatures ranging from (272.7 to 288.7) K. An isochoric pressure-search method was used to perform the measurements. A thermodynamic model based on the van der Waals–Platteeuw (vdW–P) model was applied for the prediction of the dissociation conditions which were compared to the experimental measurements. The fluid phase was modeled using the MHV2 G^E-EoS mixing rule along with the UNIFAC (original) activity model. The van der Waals–Platteeuw (vdW–P) model was used for the modeling of the hydrate phase. There was reasonable agreement between the experimental and predicted values.     

Enantioselective drug monitoring of (R)- and (S)- propranolol in human plasma via derivatization with optically active (R,R)-O,O-diacetyl tartaric acid anhydride

A sensitive high-performance liquid chromatographic method was developed for the stereoselective assay of (R)- and (S)-propranolol in human plasma. The method involves diethyl ether extraction of the drugs and a racemic internal standard, N-tert.-butylpropranolol, followed by derivatization of the compounds with the chiral reagent (R,R)-O,O-diacetyl tartaric acid anhydride. The resulting diastereomeric derivatives were separated isocratically on a reversed-phase column. Quantitation was achieved by the peak-height ratio method with reference to the internal standard. The assay was accurate and reproducible in the concentration range 1-100 ng of (R)- and (S)-propranolol per ml plasma, using fluorescence detection at lambda ex 290 nm and lambda em 335 nm. The applicability of this method was demonstrated for the determination of concentration-time profiles of propranolol enantiomers in the course of comparative pharmacokinetic studies.     

Heterotricyclodecane VIII. (−)-(1S, 3R, 6R, 8R)-2, 7-Dioxaisotwistan und (−)-(1R, 3R, 6R, 8R)-2, 7-Dioxa-twistan; Synthese und Bestimmung der absoluten Konfiguration

A synthesis and the determination of the absolute configuration of (?)-(1S, 3R′ 6R, 8R)-2, 7-dioxa-isotwistane ( 13 ) and (?)-(1R, 3R, 6R, 8R)-2, 7-dioxa-twistane ( 14 ) is described. The results for 14 are compared with those for carboeyclic (+)-twistane ( 2 ) of known chirality.     

二乙酰酒石酸酐柱前手性衍生化反相高效液相色谱法拆分心得安对映体

以（Ｒ，Ｒ）－Ｏ，Ｏ－二乙酰基酒石酸酐作柱前手性衍生化试剂，用ＯＤＳ柱拆分了心得安对映体，探讨了衍生化反应条件，研究了ＰＨ及流动相组成对色谱保留行为的影响，发现心得安的两种非对映异构体衍生物的荧光响应有显著差别，对心得安对映体的半制备色谱拆分规律作了新的探讨，确定用Ｓｈｉｍ－ｐａｃｋＣＬＣ－ＯＤＳ柱进行半制备色谱拆分的最佳条件，得到的光学异构体纯度在９９％以上。     

Asymmetric synthesis of (4R,5R)-cytoxazone and (4R,5S)-epi-cytoxazone

(4R,5R)-Cytoxazone has been prepared in four steps and in 61% overall yield and >98% ee. Conjugate addition of lithium (R)-N-benzyl-N-[small alpha]-methylbenzylamide to tert-butyl (E)-3-(p-methoxyphenyl)prop-2-enoate and subsequent in situ diastereoselective enolate oxidation with (+)-(camphorsulfonyl)oxaziridine gave tert-butyl (2R,3R,[small alpha]R)-2-hydroxy-3-(p-methoxyphenyl)-3-(N-benzyl-N-[small alpha]-methylbenzylamino)propanoate in >98% de. Subsequent N-benzyl deprotection to the primary [small beta]-amino ester via hydrogenolysis, oxazolidinone formation with C(2)-retention by treatment with diphosgene and chemoselective ester reduction furnishes (4R,5R)-cytoxazone. The synthesis of the C(5)-epimer, (4R,5S)-epi-cytoxazone in 44% overall yield, has also been completed via a protocol involving N-Boc protection of the primary [small beta]-amino ester, utilization of the N-Boc group to facilitate simultaneous C(2)-inversion and oxazolidinone formation, and subsequent reduction.     

Chemoenzymatic asymmetric total syntheses of antitumor agents (3R,9R,10R)- and (3S,9R,10R)-Panaxytriol and (R)- and (S)-Falcarinol from Panax ginseng using an enantioconvergent enzyme-triggered cascade reaction

Total asymmetric synthesis of two components of Panax ginseng showing antitumor activity, i.e., (3R,9R,10R)- and (3S,9R,10R)-Panaxytriol and of both enantiomers of Falcarinol was accomplished. Due to the fact that the synthetic strategy was based on enantioconvergent biotransformations, the occurrence of any undesired stereoisomer was entirely avoided. The absolute configuration of naturally occurring Panaxytriol was confirmed to be (3R,9R,10R) on the basis of optical rotation values. It was shown that enzyme-triggered cascade reactions represent a valuable tool for the synthesis of natural products.     

A Convenient Method for Synthesis of Novel Cyclic Ethers (1R,2R,3R,5S,7S,9R,12R)-3-(t-Butyldimethylsilyl)oxy-7-methoxymethyl-oxy-2,10-dimethyl-12-oxatricyclo [7.2.1.0~(5,12)] dodecane

Coloradocin, a novel macrolide antibiotic from cultures of Actinoplanes coloradoensis1exhibits activity against pathogenic anaerobic and microaerophilic species2. Because itslow toxicity and substantial oral activity3, , as well as its unusual structure5, several 4research groups initiated approaches towards the synthesis of coloradocin6, whichculminated in the synthesis of 18-deoxynargenicin A1 by Kallmerten et al.7. …